These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36065620)

  • 1. A Catalytic Immune Activator Based on Magnetic Nanoparticles to Reprogram the Immunoecology of Breast Cancer from "Cold" to "Hot" State.
    Wang S; Wang Z; Li Z; Xu J; Meng X; Zhao Z; Hou Y
    Adv Healthc Mater; 2022 Nov; 11(21):e2201240. PubMed ID: 36065620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
    Jing Z; Li Y; Song J; Zang X
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
    Zhang J; Zuo T; Liang X; Xu Y; Yang Y; Fang T; Li J; Chen D; Shen Q
    J Mater Chem B; 2019 Dec; 7(45):7141-7151. PubMed ID: 31663577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Au-Fe
    Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
    J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming Intratumor Bacteria into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer.
    Liu X; Sun M; Pu F; Ren J; Qu X
    J Am Chem Soc; 2023 Dec; 145(48):26296-26307. PubMed ID: 37987621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
    Chen X; Jia Z; Wen Y; Huang Y; Yuan X; Chen Y; Liu Y; Liu J
    Acta Biomater; 2022 Oct; 151():537-548. PubMed ID: 35981687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-in-One Theranostic Nanomedicine with Ultrabright Second Near-Infrared Emission for Tumor-Modulated Bioimaging and Chemodynamic/Photodynamic Therapy.
    Xu J; Shi R; Chen G; Dong S; Yang P; Zhang Z; Niu N; Gai S; He F; Fu Y; Lin J
    ACS Nano; 2020 Aug; 14(8):9613-9625. PubMed ID: 32806021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Reactive Oxygen Species Nanoreactor for Switchable Magnetic Resonance Imaging Guided Cancer Therapy Based on pH-Sensitive Fe
    Yu J; Zhao F; Gao W; Yang X; Ju Y; Zhao L; Guo W; Xie J; Liang XJ; Tao X; Li J; Ying Y; Li W; Zheng J; Qiao L; Xiong S; Mou X; Che S; Hou Y
    ACS Nano; 2019 Sep; 13(9):10002-10014. PubMed ID: 31433945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Chemodynamic Therapy by Cu-Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction.
    Koo S; Park OK; Kim J; Han SI; Yoo TY; Lee N; Kim YG; Kim H; Lim C; Bae JS; Yoo J; Kim D; Choi SH; Hyeon T
    ACS Nano; 2022 Feb; 16(2):2535-2545. PubMed ID: 35080370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Specific Endogenous Fe
    Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFB targeting biodegradable FePt alloy assembly for MRI guided starvation-enhancing chemodynamic therapy of cancer.
    Zhang C; Leng Z; Wang Y; Ran L; Qin X; Xin H; Xu X; Zhang G; Xu Z
    J Nanobiotechnology; 2022 Jun; 20(1):264. PubMed ID: 35672821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy.
    Wang T; Zhang H; Qiu W; Han Y; Liu H; Li Z
    Bioact Mater; 2022 Oct; 16():418-432. PubMed ID: 35386309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable MnO-Based Nanoparticles with Engineering Surface for Tumor Therapy: Simultaneous Fenton-Like Ion Delivery and Immune Activation.
    Sun Z; Wang Z; Wang T; Wang J; Zhang H; Li Z; Wang S; Sheng F; Yu J; Hou Y
    ACS Nano; 2022 Aug; 16(8):11862-11875. PubMed ID: 35925671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasmall Ternary FePtMn Nanocrystals with Acidity-Triggered Dual-Ions Release and Hypoxia Relief for Multimodal Synergistic Chemodynamic/Photodynamic/Photothermal Cancer Therapy.
    Yang B; Dai Z; Zhang G; Hu Z; Yao X; Wang S; Liu Q; Zheng X
    Adv Healthc Mater; 2020 Nov; 9(21):e1901634. PubMed ID: 32959536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
    Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy.
    Xu L; Weng S; Li S; Wang K; Shen Y; Xu Y; Tang C; Yin C
    ACS Nano; 2023 Jun; 17(12):11817-11837. PubMed ID: 37318192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy.
    Liu Y; Zhang D; Zhang Z; Liang X; Yang X; Ding N; Nie Y; Li C
    J Colloid Interface Sci; 2024 Mar; 657():598-610. PubMed ID: 38071809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.